Pesquisas alternativas:
loss develop » locus develop (Expandir a Pesquisa), boys develop (Expandir a Pesquisa), less developed (Expandir a Pesquisa)
develop type » developing type (Expandir a Pesquisa)
devel ther » novel ther (Expandir a Pesquisa), level theory (Expandir a Pesquisa)
drug loss » drug lots (Expandir a Pesquisa), drug cross (Expandir a Pesquisa), drug lists (Expandir a Pesquisa)
de devel » de deve (Expandir a Pesquisa), de dever (Expandir a Pesquisa), de deber (Expandir a Pesquisa)
drug de » drug dose (Expandir a Pesquisa), drug dna (Expandir a Pesquisa)
loss develop » locus develop (Expandir a Pesquisa), boys develop (Expandir a Pesquisa), less developed (Expandir a Pesquisa)
develop type » developing type (Expandir a Pesquisa)
devel ther » novel ther (Expandir a Pesquisa), level theory (Expandir a Pesquisa)
drug loss » drug lots (Expandir a Pesquisa), drug cross (Expandir a Pesquisa), drug lists (Expandir a Pesquisa)
de devel » de deve (Expandir a Pesquisa), de dever (Expandir a Pesquisa), de deber (Expandir a Pesquisa)
drug de » drug dose (Expandir a Pesquisa), drug dna (Expandir a Pesquisa)
141
Por Moreira, Taís de Campos, Signor, Luciana, Figueiró, Luciana Rizzieri, Fernandes, Simone, Bortolon, Cassandra Borges, Benchaya, Mariana Canellas, Ferigolo, Maristela, Barros, Helena MT
Publicado em 2014
“...OBJECTIVE: To estimate rates of non-adherence to telemedicine strategies aimed at treating drug...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
142
“...Type 2 diabetes mellitus (T2DM) is rapidly increasing in prevalence and is a major public health...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
143
Por Oshakbayev, Kuat, Dukenbayeva, Bibazhar, Otarbayev, Nurzhan, Togizbayeva, Gulnar, Tabynbayev, Nariman, Gazaliyeva, Meruyert, Idrisov, Alisher, Oshakbayev, Pernekul
Publicado no Nutr J (2015)
“... the effectiveness of a weight loss program in AS patients in randomized controlled trial, and to develop a...”Publicado no Nutr J (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
144
“... inhibitor of the de novo pyrimidine biosynthesis. We also discuss new unexpected mechanisms of these drugs...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
145
“... show here that the predominantly Golgi-resident Na(+)/H(+) exchanger NHE8 localizes to the developing...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
146
Por Mumford, Sunni L., Silver, Robert M., Sjaarda, Lindsey A., Wactawski-Wende, Jean, Townsend, Janet M., Lynch, Anne M., Galai, Noya, Lesher, Laurie L., Faraggi, David, Perkins, Neil J., Schliep, Karen C., Zarek, Shvetha M., Schisterman, Enrique F.
Publicado no Hum Reprod (2016)
“... or type of pregnancy loss among women with a history of one to two prior pregnancy losses. WHAT IS KNOWN...”Publicado no Hum Reprod (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
147
Por Carmody, Jill S., Ahmad, Nadia N., Machineni, Sriram, Lajoie, Scott, Kaplan, Lee M.
Publicado no Endocrinology (2015)
“...Roux-en-Y gastric bypass (RYGB) typically leads to substantial, long-term weight loss (WL...”Publicado no Endocrinology (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
148
Por Noonan, Haley R., Metelo, Ana M., Kamei, Caramai N., Peterson, Randall T., Drummond, Iain A., Iliopoulos, Othon
Publicado no Dis Model Mech (2016)
“... to the development of several tumor types including clear cell renal cell carcinoma (ccRCC). In addition, the VHL...”Publicado no Dis Model Mech (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
149
Por Huang, Liang, Shimoji, Mika, Wang, Juan, Shah, Salim, Kamila, Sukanta, Biehl, Edward R., Lim, Seung, Chang, Allison, Maguire-Zeiss, Kathleen A., Su, Xiaomin, Federoff, Howard J.
Publicado em 2013
“...The pathogenic mechanism(s) contributing to loss of dopamine neurons in Parkinson’s disease (PD...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
150
“... is expressed in multiple tumor types, in cancer cell lines, and in tumors from animal models, and the function...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
151
Por Candeias, Emanuel Monteiro, Sebastião, Inês Carolina, Cardoso, Susana Maria, Correia, Sónia Catarina, Carvalho, Cristina Isabel, Plácido, Ana Isabel, Santos, Maria Sancha, Oliveira, Catarina Resende, Moreira, Paula Isabel, Duarte, Ana Isabel
Publicado no World J Diabetes (2015)
“...Long-acting glucagon-like peptide-1 (GLP-1) analogues marketed for type 2 diabetes (T2D) treatment...”Publicado no World J Diabetes (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
152
“... for the approval of antiobesity drugs has been raised. Although >5% of placebo-subtracted weight loss maintained...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
153
“...The first major recognition of drug-induced hearing loss can be traced back more than seven decades...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
154
Por Hutchings, Adam, Schey, Carina, Dutton, Richard, Achana, Felix, Antonov, Karolina
Publicado em 2014
“... approvals, average cost of OMPs, and the type of companies developing OMPs....”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
155
156
Por Wang, Shaobo, Liu, Yang, Guo, Jiao, Wang, Peilin, Zhang, Leike, Xiao, Gengfu, Wang, Wei
Publicado no J Virol (2017)
“... of the five hit drugs were calcium inhibitors, additional types of calcium inhibitors that confirmed...”Publicado no J Virol (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
157
“... necessary for rational drug development and other clinical applications....”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
158
Por A. O. Elagina, A. V. Beliatskaya, I. I. Krasnyuk (Jr.), I. I. Krasnyuk, O. I. Stepanova, A. N. Vorob'yov, T. V. Fateeva
Publicado em 2022-02-01
“... life of drugs".Results and discussion. We developed he composition and technology of FZ effervescent...”Publicado em 2022-02-01
Obter o texto integral
Artigo
159
Por Takahashi, Ryou-u, Miyazaki, Hiroaki, Takeshita, Fumitaka, Yamamoto, Yusuke, Minoura, Kaho, Ono, Makiko, Kodaira, Makoto, Tamura, Kenji, Mori, Masaki, Ochiya, Takahiro
Publicado no Nat Commun (2015)
“...Cancer stem cells (CSCs) have been identified in various types of cancer; however, the mechanisms...”Publicado no Nat Commun (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
160
Por Ammoun, Dr Sylwia, Maze, Mr Emmanuel, Reeves, Ms Shona, Hilton, Dr David, Ercolano, Dr Emanuela, Hamemann, Prof Oliver, Belshaw, Dr Robert
Publicado no Neuro Oncol (2017)
“...Loss of function mutations in the gene coding for the tumour suppressor Merlin causes development...”Publicado no Neuro Oncol (2017)
Obter o texto integral
Obter o texto integral
Artigo